Question to the Department of Health and Social Care:

To ask Her Majesty's Government whether Avastin has approval from the European Medicines Authority to be used to treat cancer.

Avastin has approval from the European Medicines Agency to be used to treat cancer in combination with specific chemotherapies in the advanced stages of several cancers. They are:

- Metastatic colorectal cancer;

- Metastatic breast cancer;

- Certain types of unresectable advanced, metastatic or recurrent lung cancer;

- Advanced or metastatic renal cell cancer;

- Advanced or recurrent or resistant ovarian/fallopian tube cancer; and

- Persistent or recurrent or metastatic cervical cancer.

Full details of the indications that Avastin is licensed for can be found in the European public assessment report for Avastin. It explains how the Agency assessed the medicine to recommend its authorisation and its conditions of use and is publicly available on their website.